Syn­cona, CRUK and BAC­IT join forces to cre­ate a $1.2B biotech in­vest­ment pow­er­house

The Well­come Trust’s in­de­pen­dent in­vest­ment sub­sidiary Syn­cona is merg­ing with the pub­lic in­vest­ment firm BAC­IT to cre­ate an ex­pand­ed, $1.2 bil­lion in­vest­ment out­fit list­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA